Melanoma response and resistance - taking it to the tumor bank
- PMID: 21781286
- PMCID: PMC8589005
- DOI: 10.1111/j.1755-148X.2011.00890.x
Melanoma response and resistance - taking it to the tumor bank
Similar articles
-
EphB4 inhibitor overcome the acquired resistance to cisplatin in melanomas xenograft model.J Pharmacol Sci. 2015 Sep;129(1):65-71. doi: 10.1016/j.jphs.2015.08.009. Epub 2015 Sep 3. J Pharmacol Sci. 2015. PMID: 26390965
-
DNA repair pathways in drug resistance in melanoma.Anticancer Drugs. 2004 Jun;15(5):421-6. doi: 10.1097/01.cad.0000127665.74096.93. Anticancer Drugs. 2004. PMID: 15166615 Review.
-
The future of combination treatment with checkpoint inhibitors in melanoma.Clin Adv Hematol Oncol. 2019 Feb;17(2):96-99. Clin Adv Hematol Oncol. 2019. PMID: 30845111 No abstract available.
-
The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma.Mol Cancer Ther. 2017 Jun;16(6):1002-1009. doi: 10.1158/1535-7163.MCT-16-0535. Mol Cancer Ther. 2017. PMID: 28576947 Review.
-
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents.Eur J Pharmacol. 2019 Nov 5;862:172621. doi: 10.1016/j.ejphar.2019.172621. Epub 2019 Aug 22. Eur J Pharmacol. 2019. PMID: 31446019 Review.
References
-
- Gerstner ER, and Fine RL (2007). Increased permeability of the blood–brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J. Clin. Oncol 25, 2306–2312. - PubMed
-
- Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, and Lunsford LD (2011). Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J. Neurosurg 114, 769–779. - PubMed
-
- Majer M, and Samlowski WE (2007). Management of metastatic melanoma patients with brain metastases. Curr. Oncol. Rep 9, 411–416. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical